RxDoctor Payments DataLook up a doctor →

David Edalati, MD

Internal Medicine · Overland Park, KSNPI 1477669141

Payments from drug & device makers

$21,378in general payments, 2019–2025

Across 1,241 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • GSK$918
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca108$2,313
AbbVie(2 entities)118$1,705
Novo Nordisk79$1,242
Lilly USA, LLC69$1,215
Pfizer79$1,122
GSK40$918
Merck59$909
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)68$790
Otsuka America Pharmaceutical, Inc.50$767
Boehringer Ingelheim34$674
Axsome Therapeutics, Inc.22$634
Viiv Healthcare Company24$549
Sunovion Pharmaceuticals Inc.30$395
Takeda Pharmaceuticals U.S.A., Inc.33$377
Johnson & Johnson(2 entities)21$374
Antares Pharma, Inc.24$360
Novartis33$358
Melinta Therapeutics, LLC17$345
Amgen(2 entities)20$329
Bayer23$311
Abbott12$305
Organogenesis Inc.13$301
Collegium Pharmaceutical, Inc.14$261
Ardelyx, Inc.9$252
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$223
Amarin Pharma, Inc.8$203
Idorsia Pharmaceuticals US Inc10$189
Almatica Pharma LLC10$178
Insmed, Inc.9$162
Biodelivery Sciences International, Inc.10$161
Currax Pharmaceuticals LLC10$142
Mylan Specialty L.p.7$136
Clarus Therapeutics Inc.4$136
Shield Therapeutics Inc2$132
Supernus Pharmaceuticals, Inc.9$131
Vanda Pharmaceuticals Inc.6$124
E.r. Squibb & Sons, L.L.C.6$111
GRT US Holding, Inc.1$101
Eisai Inc.7$98
Ironwood Pharmaceuticals, Inc7$97
Acelrx Pharmaceuticals, Inc.1$97
Teva Pharmaceuticals USA, Inc.6$94
Paratek Pharmaceuticals, Inc.5$85
Scilex Pharmaceuticals Inc.6$85
Astellas Pharma US Inc4$83
Zyla Life Sciences, Inc.5$81
Endo Pharmaceuticals Inc.5$77
Biogen4$76
Kyowa Kirin, Inc.4$72
Arbor Pharmaceuticals, Inc.5$71
Azurity Pharmaceuticals, Inc.4$71
Convatec Inc.3$70
Mallinckrodt Hospital Products Inc.3$65
Biohaven Pharmaceutical Holding Company Ltd.3$64
Phathom Pharmaceuticals, Inc.3$57
Amneal Pharmaceuticals LLC3$51
Verona Pharma, Inc.3$47
Next Science LLC2$47
Viatris Specialty LLC2$42
Protega Pharmaceutials Inc2$42

How this compares

$21,378 in reported general payments places this provider in the 95th percentile of 705 internal medicine providers in Kansas.

See all internal medicine providers in Kansas →

Medicare billing

Part B allowed, 2024
$286,818
Medicare patients
249
Services billed
3,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Overland Park

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →